Study Stopped
No funding
Fluorescent Cholangiography and Bile Duct Stones
Sensitivity and Specificity of Fluorescent Cholangiography to Detect Bile Duct Stones in Patients Undergoing Laparoscopic Cholecystectomy
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Background. X-ray cholangiography has a high sensitivity and specificity of detecting bile duct stones and is the gold standard. There are no studies describing the sensitivity and specificity of IFC for bile duct stone detection. Research question. What is the sensitivity of IFC to visualize bile duct stones? Method. Prospective study with 40 patients undergoing planned laparoscopic cholecystectomy with preoperative magnetic resonance cholangiopancreatography (MRCP) (gold standard) and intraoperative IFC, X-ray cholangiography and choledochuscopy in that order. Primary outcome. Sensitivity of visualization of bile duct stone by fluorescent cholangiography and secondary outcome is visualization of anatomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2018
CompletedFirst Posted
Study publicly available on registry
May 21, 2018
CompletedStudy Start
First participant enrolled
March 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedFebruary 28, 2024
February 1, 2024
1.6 years
May 8, 2018
February 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity and specificity
Sensitivity and specificity of visualization of bile duct stones by intraoperative fluorescent cholangiography
120mins
Secondary Outcomes (1)
Visualization
120mins
Study Arms (2)
MRCP positive
EXPERIMENTALMRCP negative
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients suspected of having bile duct stones by either blood samples, MRCP or medical history (see definitions)
- Patient age ≥ 18 years
- Preoperative MRCP
- Operation performed by a project surgeon
You may not qualify if:
- Open cholecystectomy (including conversion from laparoscopic to open)
- Acute cholecytitis or cholangitis
- Pancreatitis
- Iodine or indocyanine green allergy
- Liver or renal insufficiency
- Thyrotoxicosis
- Cholecystectomy not the primary surgical procedure
- Pregnancy or lactation
- Legally incompetent for any reason
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hvidovre University Hospital
Holte, Danmark, 2840, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars L Lehrskov, MD
Hvidovre University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 8, 2018
First Posted
May 21, 2018
Study Start
March 25, 2019
Primary Completion
October 31, 2020
Study Completion
August 1, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02